Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapy resistance in neuroblastoma: Mechanisms and reversal strategies. | Front Pharmacol | 2023 | 36874032 | PubTator, text mining | PubMed |
| Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. | Front Pharmacol | 2023 | 36874010 | PubTator, text mining | PubMed |
| [Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression]. | Zhongguo Fei Ai Za Zhi | 2023 | 36872049 | PubTator, text mining | PubMed |
| Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer. | Sci Rep | 2023 | 36869231 | PubTator, text mining | PubMed |
| ACSL1, CH25H, GPCPD1, and PLA2G12A as the potential lipid-related diagnostic biomarkers of acute myocardial infarction. | Aging (Albany NY) | 2023 | 36863716 | PubTator, text mining | PubMed |
| Potential value of efficacy prediction and treatment of natural killer cells in extensive stage small cell lung cancer. | Thorac Cancer | 2023 | 36861174 | PubTator, text mining | PubMed |
| Generation of glutamatergic/GABAergic neuronal co-cultures derived from human induced pluripotent stem cells for characterizing E/I balance in vitro. | STAR Protoc | 2023 | 36856768 | PubTator, text mining | PubMed |
| Editorial: Advanced computational systems biology approaches for accelerating comprehensive research of the human brain. | Front Genet | 2023 | 36845385 | PubTator, text mining | PubMed |
| Mapping Spatiotemporal Heterogeneity in Tumor Profiles by Integrating High-Throughput Imaging and Omics Analysis. | ACS Omega | 2023 | 36844580 | PubTator, text mining | PubMed |
| Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells. | Mod Pathol | 2023 | 36841178 | PubTator, text mining | PubMed |
| An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma. | Cancer Sci | 2023 | 36840413 | PubTator, text mining | PubMed |
| ANO4 Expression Is a Potential Prognostic Biomarker in Non-Metastasized Clear Cell Renal Cell Carcinoma. | J Pers Med | 2023 | 36836529 | PubTator, text mining | PubMed |
| ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid. | Int J Mol Sci | 2023 | 36835157 | PubTator, text mining | PubMed |
| Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer. | Int J Mol Sci | 2023 | 36835130 | PubTator, text mining | PubMed |
| Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer. | Int J Mol Sci | 2023 | 36834602 | PubTator, text mining | PubMed |
| High-Precision Detection of Cellular Drug Response Based on SERS Spectrum and Multivariate Statistical Analysis. | Biosensors (Basel) | 2023 | 36832007 | PubTator, text mining | PubMed |
| Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson's Disease Patient. | Cells | 2023 | 36831291 | PubTator, text mining | PubMed |
| Direct Cell Reprogramming and Phenotypic Conversion: An Analysis of Experimental Attempts to Transform Astrocytes into Neurons in Adult Animals. | Cells | 2023 | 36831283 | PubTator, text mining | PubMed |
| Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. | Biomedicines | 2023 | 36830921 | PubTator, text mining | PubMed |
| Massively parallel characterization of psychiatric disorder-associated and cell-type-specific regulatory elements in the developing human cortex. | bioRxiv | 2023 | 36824845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=40